“As time goes by, I cope with it better and better. I’ll never be completely free from worry. But I worry a lot less now.” Lesley, a soldier and father of three, led a busy life. When he learned that he had #cancer, his first concern was for his family.
Kite Pharma
Biotechnology Research
Santa Monica, California 146,982 followers
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
About us
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit. Since 2009, Kite has been at the forefront of cancer immunotherapy. Today, we are proud to be the leader in engineered T cell therapy for hematologic malignancies, but we recognize that this is just the beginning. Patients are at the heart of our focus on the cure, which is why we are committed to pursuing cell therapy as a transformative treatment option for as many people with cancer as possible who may benefit. Cancer is personal to us. Unlike traditional pharmaceutical manufacturing, our therapies are not created on an assembly line. Cell therapy specialists at our manufacturing facilities reengineer a patient’s own immune cells to attack and fight their cancer cells — one patient at a time. That sense of connection to the people we serve motivates us daily at Kite. Our corporate headquarters are located in Santa Monica, California, and we have dedicated cell therapy manufacturing facilities in California, Maryland and the Netherlands. If you’re passionate about changing the future of cancer treatment, let’s talk. See our community guidelines: http://bit.ly/2DznMNw
- Website
-
http://www.kitepharma.com
External link for Kite Pharma
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Santa Monica, California
- Type
- Public Company
- Founded
- 2009
- Specialties
- Cancer Treatment, Engineered Autologous Cell Therapy (eACT), Immunotherapy, T-Cells, and cell therapy
Locations
Employees at Kite Pharma
Updates
-
Gilead Sciences and Kite have both been recognized by the Association of Energy Engineers for outstanding contributions to the field of energy efficiency and sustainability. Gilead was honored with an International Award and Kite with two Regional Awards for its #celltherapy facilities in Frederick, MD and Santa Monica, CA. Our passion for creating a better, healthier world drives us to be responsible corporate citizens.
-
Kite Pharma reposted this
During #PrideMonth, Gilead and Kite Pharma employees, families and friends proudly participated in the San Francisco Pride and WeHo Pride parades to celebrate the LGBTQ+ community, embodying our theme of “live, love, liberate” -- an anthem of equality and inclusion for all.
-
-
This week, Kite colleagues volunteered by packing comfort kits for people with cancer and their loved ones. Thank you to the Cancer Support Community Los Angeles for your positive impact on individuals and families in our community.
-
-
Thank you to The Surfrider Foundation for hosting us for a beach cleanup day in Santa Monica. Kite teammates volunteered as part of our Month of Service.
-
-
Gilead Sciences and Kite teammates shared what #Juneteenth means to them and gathered for a flag raising ceremony, emphasizing the significance of this important day in American history. The event was an opportunity to reflect and recognize Juneteenth.
“Today is a symbol of hope and progress, and a testament to the importance of remembering our past while forging a better future.” Remi Mullins Murphy, a member of the Gilead Leadership Organization of Black Employees (GLOBE) Employee Resource Group, shares what #Juneteenth means to her and the significance of Gilead’s annual flag raising.
-
We enjoyed being part of the European Hematology Association (EHA) Congress 2024 and discussing the latest in research and care for people living with blood cancer. We are proud to be part of the #hematology community and remain committed to changing the future of blood cancer treatment. #EHA2024
-
-
At the European Hematology Association (EHA) 2024 Congress, we presented new data on how we can bring CAR T-cell therapies closer to home to reach more eligible people living with blood cancer. Kite’s Global Head of Medical Affairs Ibrahim Elhoussieny, MD, highlights the feasibility of making outpatient CAR T a reality. #EHA2024
-
#KiteNews: At the European Hematology Association (EHA) Congress 2024, we announced results from three new analyses for #CARTcell therapy in relapsed/refractory large B-cell lymphoma, including both new clinical research and real-world evidence highlighting manufacturing and product characteristics. #EHA2024 Read more: https://bit.ly/4ekeANb
-
-
CAR T-cell therapies are changing the way cancer is treated. Ahead of the European Hematology Association (EHA) 2024 Congress, Kite’s Global Head of Medical Affairs Ibrahim Elhoussieny, MD, discusses how we can reach more eligible patients through the manufacturing of these highly individualized treatments. #EHA2024